Breakthrough: FDA Approves Groundbreaking Anti-Inflammatory Drug for Heart Health
The FDA has approved LODOCO (colchicine), the first anti-inflammatory drug for cardiovascular disease. This medication has been shown to reduce the risk of cardiac events in adults with atherosclerotic cardiovascular disease or multiple risk factors by an additional 31% compared to standard-of-care treatment. LODOCO can be used alone or in combination with cholesterol-lowering medications. The approval highlights the importance of inflammation as a risk factor for heart disease and encourages lifestyle choices that can help lower inflammation.